spacer
home > pmps > winter 2002 > label materials for small diameter applications
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Label Materials For Small Diameter Applications

There is no wider area for different types of packaging than the pharmaceutical and medical industries. One look in any pharmacy reveals all types of differently packaged products. Medicines prescribed by a doctor might, for example, be packaged in classic style amber glass bottles with a matt or gloss paper label simply containing data about the medicines. Over the counter (OTC) products are packed in a white polyethylene (PE) container decorated with a multicolour printed high-gloss label. In such cases, suitable labelling materials may be found relatively easily.

However, pharmaceutical labelling applications often involve small diameters. With medical ingredients found in increasingly concentrated dosages, there is a trend towards smaller diameter packaging. And when a squeezable low-density polyethylene (LDPE) nose or eye drop container needs to be labelled, things start to look rather different.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Sven Tolsma, Product Manager at Raflatac
Sven Tolsma has 18 years' work experience in the graphics and paper industries, and has worked for Raflatac since 1994. Raflatac is a leading supplier of paper-based and synthetic self-adhesive labelstock, the material used to make self-adhesive laminate for a wide variety of needs in product and information labelling. Sven was promoted to Product Manager in 1998 and is currently working as part of a product marketing team.

He is responsible for gloss-coated and mid-gloss coated papers, and specialises in pharmaceutical and tyre labelling. He is responsible for identifying supply and demand, applications and trends, and predicting their effect on the labelling industry. Sven utilises this market information to educate end-users' application engineers and label converters' sales forces, as well as the sales force and technical service at Raflatac.

spacer
Sven Tolsma
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Avacta and Cytiva collaborating on COVID-19 rapid test

Cambridge and Wetherby, UK, 08 April 2020: Avacta Group plc (AIM: AVCT), the developer of AffimerŽ biotherapeutics and reagents, is pleased to announce that it has entered into a collaboration with Cytiva, formerly known as GE Healthcare Life Sciences. The companies will develop and manufacture an Affimer-based point-of-care rapid test intended for screening of large populations to diagnose the COVID-19 coronavirus infection.
More info >>

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement